Domov › Rakovina (všetky typy) › Indiana › Indianapolis
Klinické štúdie Rakovina (všetky typy) v meste Indianapolis, IN
24 štúdií pre Rakovina (všetky typy) hľadá účastníkov v zariadeniach v meste Indianapolis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Daily Hand-Held Vibration Therapy
Prebieha nábor
- Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
- IU Health Joe & Shelly Schwarz Cancer Center, Indianapolis
- Indiana University Health West, Avon · 13 míľ odtiaľ
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Prebieha náborObservačná štúdia
- Indiana University, Indianapolis
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Prebieha náborFáza 3
- Franciscan Health Oncology and Hematology Specialists, Indianapolis
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Prebieha náborFáza 3
- Franciscan St. Francis Health /ID# 279788, Indianapolis
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Prebieha náborFáza 2
- Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- Community Health Network, Indianapolis
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Prebieha náborFáza 2/3
- IN Univ Simon Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
Collection of Tissue Samples for Cancer Research
Prebieha náborObservačná štúdia
- Indiana University - Purdue, Indianapolis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- Community Cancer Center North, Indianapolis
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Prebieha náborFáza 2
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Project: Every Child for Younger Patients With Cancer
Prebieha náborObservačná štúdia
- Riley Hospital for Children, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Prebieha náborFáza 3
- Franciscan Health, Indianapolis
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Prebieha náborFáza 3
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
- a 1 ďalších
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Prebieha náborFáza 1
- Franciscan St. Francis Health /ID# 280928, Indianapolis
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Prebieha náborFáza 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Prebieha náborVítaní zdravých dobrovoľníkov
- Indiana University School of Medicine, Indianapolis
Childhood Cancer Survivor Study
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Indiana University/Riley Hospital for Children, Indianapolis
Galleri® in the Medicare Population.
Prebieha náborVítaní zdravých dobrovoľníkov
- Community Health Network East, Indianapolis
- Community Health Network South, Indianapolis
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Prebieha nábor
- University Hospital Clinical Research Center, Indianapolis
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Prebieha nábor
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
GEMINI-NSCLC: NSCLC Biomarker Study
Prebieha náborObservačná štúdia
- Community Health Network, Indianapolis
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- IU Simon Comprehensive Cancer Center, Indianapolis
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Prebieha náborFáza 1/2
- Community Health Network, Inc., Indianapolis
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Prebieha nábor
- Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
Štúdie Rakovina (všetky typy) v iných mestách
- Houston, TX121 štúdií
- New York City, NY109 štúdií
- Boston, MA85 štúdií
- Los Angeles, CA74 štúdií
- Nashville, TN65 štúdií
- Philadelphia, PA59 štúdií
- Washington, DC58 štúdií
- Durham, NC58 štúdií
- Chicago, IL51 štúdií
- Atlanta, GA49 štúdií
- Seattle, WA49 štúdií
- Arlington, VA48 štúdií
Iné štúdie v Indianapolis
- Nemalobunkový karcinóm pľúc32 štúdií
- Srdcové zlyhanie23 štúdií
- Obézita20 štúdií
- Rakovina prsníka20 štúdií
- Metastatická rakovina19 štúdií
- Kolorektálny karcinóm18 štúdií
- Rakovina vaječníkov17 štúdií
- Kardiovaskulárne ochorenia17 štúdií
- Rakovina pľúc16 štúdií
- Diabetes mellitus 1. typu14 štúdií
- Rakovina endometria14 štúdií
- Alzheimerova choroba14 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.